LENSAR Inc

LNSR NASDAQ Santé & Biotech États-Unis US52634L1089
5.90 $
3.11 %

LENSAR, Inc. se concentre sur le développement et la commercialisation de de chirurgie réfractive avancées pour les patients souffrant de cataracte.

Performance & Momentum

6 Months 44.54 %
1 Year 59.48 %
3 Years 108.12 %
5 Years 29.41 %

Similar stocks to LENSAR Inc

Anantys Community

Be the first to share your analysis on LENSAR Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases